| Name | Walgreens #4662 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 3045 Broadway Blvd, Garland, Texas 75041 |
| Type | Supplier |
| Phone | (972) 864-1608 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Meanwhile, the Obama administration announced it would add new funds to increase access to HIV/AIDS care, but questions remain about whether it will be enough to address waiting lists for the drug assistance program. Also in the news, reports on treatment developments.
Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
St. Jude Children's Research Hospital scientists have discovered how an important "on" switch is attached to the machinery that cells rely on to adapt thousands of proteins to meet changing conditions.
Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well.
› Verified 5 days ago
News Archive
Meanwhile, the Obama administration announced it would add new funds to increase access to HIV/AIDS care, but questions remain about whether it will be enough to address waiting lists for the drug assistance program. Also in the news, reports on treatment developments.
Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
St. Jude Children's Research Hospital scientists have discovered how an important "on" switch is attached to the machinery that cells rely on to adapt thousands of proteins to meet changing conditions.
Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well.
› Verified 5 days ago
Aids For Recovery Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1311 Marketplace Dr, Garland, Texas 75041 Phone: (214) 328-0677 | |
Sav-on Pharmacy #4265 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5710 Broadway Blvd, Garland, Texas 75043 Phone: (972) 240-7438 | |
Carechoice Pharmacy Type: Medicare Supplier Location: 813 N Jupiter Rd, Garland, Texas 75042 Phone: (469) 929-6430 | |
Cvs Pharmacy # 07824 Type: Pharmacy Location: 5702 Lavon Dr, Garland, Texas 75040 Phone: (972) 495-5595 | |
Cvs Pharmacy #04777 Type: Pharmacy Location: 3034 South 1st Street, Garland, Texas 75041 Phone: (972) 271-3801 |